Neuralink Corp., the brain-implant company founded by Elon Musk, has successfully raised $280 million in new funding to further develop its innovative technology. The funding round, which was announced on Musk's X social network (formerly known as Twitter), was led by Founders Fund, a prominent venture capital firm backed by billionaire Peter Thiel.
As the leading player in the rapidly expanding field of brain technology, Neuralink has garnered significant attention and interest from investors. This heightened interest has also spurred investments in numerous other startups that are exploring similar technologies. According to PitchBook data, neurotechnology startups raised $143 million in funding in the first half of this year alone, surpassing the total funding raised in the entire year of 2022 ($278.1 million) and 2021 ($518.9 million). One notable rival, Synchron Inc., managed to enroll its first patient in a clinical trial in the United States before Neuralink could achieve that milestone.
The recent funding round comes on the heels of Neuralink receiving approval from the US Food and Drug Administration (FDA) to conduct human clinical trials. The company aims to develop a small device comprising of electrode-laced wires that can establish a direct connection between the brain and a computer. However, the placement of this device necessitates drilling into the skull, giving rise to concerns and ethical considerations.
Neuralink has faced criticism from animal rights groups in the past due to its testing on primates. Earlier this year, the US Transportation Department initiated an investigation into the company following allegations from an animal advocacy organization. The organization claimed to have obtained emails suggesting that Neuralink did not adhere to proper protocols while shipping potentially hazardous materials.
With the influx of new funding, Neuralink is poised to push forward with its ambitious goals and make significant strides in the field of brain implant technology. As the company continues its research and development efforts, it remains to be seen how Neuralink's innovative technology will shape the future of neuroscience and human-computer interfaces.